Dabigatran and left atrial appendage thrombus
- 1k Downloads
A 59-year-old white woman with previous history of arterial hypertension consulted because of palpitations. Atrial fibrillation of uncertain duration was diagnosed. She was not receiving anticoagulants. A trans-esophageal echocardiogram was performed, and a large left atrial appendage thrombus was detected. A strategy of rate control and anti-vitamin K treatment was started. On the subsequent days, we could not reach therapeutic INRs. Therefore, it was decided to stop warfarin and initiate dabigatran. We describe the evolution of the patient, the thrombus resolution, and a successful electrical cardioversion. In our comments, we summarize the natural history of left atrial thrombus, both with and without anticoagulant therapy. We also discuss the differences between warfarin and dabigatran.
KeywordsThrombus Dabigatran Atrial fibrillation
Conflict of interest
The authors declare that they have no conflict interests.
- 8.Thambidorai SK, Murray RD, Parakh K, Shah TK, Black IW, Jasper SE, Li J, Apperson-Hansen C, Asher CR, Grimm RA (2005) ACUTE investigators. utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study). Am J Cardiol 96:935–941PubMedCrossRefGoogle Scholar
- 12.Sinnaeve PR, Huang Y, Bogaerts K, Vahanian A, Adgey J, Armstrong PW, Wallentin L, Van de Werf FJ (2006) age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: findings from assessment of the Safety and Efficacy of a new Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS. Am Heart J 152(684):e1–e9PubMedGoogle Scholar
- 13.Connolly SJ, Ezekowitz MD, Yusuf S, et al., and the RE-LY Steering Committee and Investigators(2009) Dabigatran versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med361:1139-1151Google Scholar